Synthetic oxytocin OT, a peptide hormone capable of stimulating uterine contractions, is one of the most common pharmacologic agents used in induction of labor (IOL). Among low-risk nulliparous patients with spontaneous labor, more than 40% receive OT augmentation. The growing rate of IOL emphasizes the need to optimize protocols for IOL and augmentation of labor. OT is frequently used to decrease the total duration of labor and complications associated with prolonged labor, including chorioamnionitis, postpartum hemorrhage, and cesarean delivery (CD). However, OT has also been associated with uterine tachysystole, which is a known risk factor for significant fetal oxygen desaturations, non reassuring fetal heart rate characteristics, and neonatal acidemia. When used for the induction or a

See Full Page